AI assistant
Aarti Drugs Limited — Call Transcript 2025
Oct 31, 2025
62194_rns_2025-10-31_a35c2c34-04db-4e60-8d39-086d4a7d0460.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [516 x 97] intentionally omitted <==
Ref: ADL/SE/2025-26/51 October 31, 2025
To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited, Dalal Street, “Exchange Plaza”, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400051 NSE SYMBOL: AARTIDRUGS BSE CODE – 524348
Dear Sir/Madam,
Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Sub: Intimation of Conference Call
This is to inform you that Quarterly Earning Conference Call for the Investors and Analysts have been scheduled on Monday, November 10, 2025 at 11:30 A.M. IST to discuss the Company’s financial performance for the Quarter and half year ended September 30, 2025.
Please find attached herewith invitation for the same.
Kindly take the same on record.
Thanking you,
Yours faithfully,
FOR AARTI DRUGS LIMITED
RUSHIKESH VIVEK DEOLE Digitally signed by RUSHIKESH VIVEK DEOLE DN: c=IN, postalCode=421301, st=MAHARASHTRA, street=THANE,B-2, DEVIPRASAD SOCIETY, AGRA ROAD ,421301, l=THANE, o=Personal, serialNumber=9b60f64457feab7f455d17463ebe710861bf01b575f6fc0484483273dabfc17f, pseudonym=39fdd8cc665b44adb709d2b2c0bc1ffe, 2.5.4.20=76af11ab2ea790a8aec8b0d90f9da6fdb715f5b922a7af009bb3f93dc014e116, [email protected], cn=RUSHIKESH VIVEK DEOLE Date: 2025.10.31 20:37:20 +05'30'
RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: F12932
==> picture [475 x 24] intentionally omitted <==
==> picture [392 x 68] intentionally omitted <==
Q2 & H1 FY26 Earnings Conference Call
DATE & TIME
10[th] November 2025 (Monday) 11:30 AM, IST (HK/Singapore 2:00 PM, UK 7:00 AM, USA 2:00 AM EST)
PARTICIPANTS
Mr. Harshit Savla – Jt. Managing Director
Mr. Harit Shah – Whole time Director
Mr. Adhish Patil – Chief Finance Officer & Chief Operating Officer Mr. Vishwa Savla – Managing Director, Pinnacle Life Science Private Limited
PRE REGISTRATION LINK – CLICK HERE
CONFERENCE DIAL-IN DETAILS
| INDIA | +91 22 6280 1309 / +91 22 7115 8210 |
|---|---|
| UNITED STATES | 1 866 746 2133 |
| UNITED KINGDOM | 0 808 101 1573 |
| SINGAPORE | 800 101 2045 |
| HONG KONG | 800 964 448 |
RSVP:
Strategic Growth Advisors Pvt. Ltd. Mr. Deven Dhruva / Ms. Krisha Shrimankar +91 98333 73300 / +91 87797 99281